Artimplant Strenghtens its Market Position

Published: Mar 20, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Artimplant (STO:ARTIB) has entered into an agreement with its licensee, Biomet Sports Medicine, Inc., to assume total responsibility for sales of ATR products.

Biomet has held the license rights for our Artelon® Tissue Reinforcement (ATR) products since 2005. During 2007, the agreement was renegotiated from exclusive to non-exclusive for the US market. In conjunction with this, Artimplant began prospecting the market independently with the aim of increasing sales of ATR products more quickly.

Back to news